1. Specific activin receptor-like kinase 3 inhibitors enhance liver regeneration. Tsugawa D, Oya Y, Masuzaki R, Ray K, Engers DW, Dib M, Do N, Kuramitsu K, Ho K, Frist A, Yu PB, Bloch KD, Lindsley CW, Hopkins CR, Hong CC, Karp SJ (2014) J Pharmacol Exp Ther 351(3): 549-58
    › Primary publication · 25271257 (PubMed) · PMC4244585 (PubMed Central)
  2. Identification of a common Wnt-associated genetic signature across multiple cell types in pulmonary arterial hypertension. West JD, Austin ED, Gaskill C, Marriott S, Baskir R, Bilousova G, Jean JC, Hemnes AR, Menon S, Bloodworth NC, Fessel JP, Kropski JA, Irwin D, Ware LB, Wheeler L, Hong CC, Meyrick B, Loyd JE, Bowman AB, Ess KC, Klemm DJ, Young PP, Merryman WD, Kotton D, Majka SM (2014) Am J Physiol Cell Physiol 307(5): C415-30
    › Primary publication · 24871858 (PubMed) · PMC4154073 (PubMed Central)
  3. Bone morphogenetic protein-focused strategies to induce cytotoxicity in lung cancer cells. Fotinos A, Nagarajan N, Martins AS, Fritz DT, Garsetti D, Lee AT, Hong CC, Rogers MB (2014) Anticancer Res 34(5): 2095-104
    › Primary publication · 24778011 (PubMed) · PMC4791537 (PubMed Central)
  4. BMP pathway regulation of and by macrophages. Talati M, West J, Zaynagetdinov R, Hong CC, Han W, Blackwell T, Robinson L, Blackwell TS, Lane K (2014) PLoS One 9(4): e94119
    › Primary publication · 24713633 (PubMed) · PMC3979749 (PubMed Central)
  5. Whole exome sequencing identifies a causal RBM20 mutation in a large pedigree with familial dilated cardiomyopathy. Wells QS, Becker JR, Su YR, Mosley JD, Weeke P, D'Aoust L, Ausborn NL, Ramirez AH, Pfotenhauer JP, Naftilan AJ, Markham L, Exil V, Roden DM, Hong CC (2013) Circ Cardiovasc Genet 6(4): 317-26
    › Primary publication · 23861363 (PubMed) · PMC3895490 (PubMed Central)
  6. Synthesis and structure-activity relationships of a novel and selective bone morphogenetic protein receptor (BMP) inhibitor derived from the pyrazolo[1.5-a]pyrimidine scaffold of dorsomorphin: the discovery of ML347 as an ALK2 versus ALK3 selective MLPCN probe. Engers DW, Frist AY, Lindsley CW, Hong CC, Hopkins CR (2013) Bioorg Med Chem Lett 23(11): 3248-52
    › Primary publication · 23639540 (PubMed) · PMC3677712 (PubMed Central)
  7. Stem cell-derived cardiomyocytes as a tool for studying proarrhythmia: a better canary in the coal mine? Roden DM, Hong CC (2013) Circulation 127(16): 1641-3
    › Primary publication · 23519759 (PubMed) · PMC3954984 (PubMed Central)
  8. Selective small molecule targeting β-catenin function discovered by in vivo chemical genetic screen. Hao J, Ao A, Zhou L, Murphy CK, Frist AY, Keel JJ, Thorne CA, Kim K, Lee E, Hong CC (2013) Cell Rep 4(5): 898-904
    › Primary publication · 24012757 (PubMed) · PMC3923627 (PubMed Central)
  9. Making Models Work: Library Annotation through Phenoclustering. Williams C, Hong C (2013) Drug Discov Today Dis Models 10(1)
    › Primary publication · 24187570 (PubMed) · PMC3811947 (PubMed Central)
  10. Bone morphogenetic protein type I receptor antagonists decrease growth and induce cell death of lung cancer cell lines. Langenfeld E, Hong CC, Lanke G, Langenfeld J (2013) PLoS One 8(4): e61256
    › Primary publication · 23593444 (PubMed) · PMC3625205 (PubMed Central)